European researchers have developed a personalized blood indicator that analyzes ten specific chemical substances to evaluate overall metabolic health, forecast the risk of chronic conditions, and track healthy aging trajectories in middle-aged adults. Presented by Joris Deelen of the Leiden University Medical Center during FAPESP Week Netherlands, the analytical tool was designed to address international health patterns where approximately 60 percent of individuals over the age of 65 currently live with two or more chronic medical conditions simultaneously. By evaluating the circulating chemical products generated during cellular function with high precision, the indicator provides a comprehensive snapshot of physiological status to identify individuals on resilient biological aging paths alongside those facing heightened probabilities of functional decline.
The development of the metric addresses pronounced disparities in healthy life expectancy documented across European populations. During his presentation, Deelen emphasized that the duration of life spent in good health after age 65 fluctuates widely depending on geography, averaging approximately four years among older adults in Romania compared with ten years among those living in the Netherlands. According to the research team, these extensive regional variations are primarily driven by differences in socioeconomic status, educational attainment, daily lifestyle habits, and underlying genetic backgrounds, creating a critical clinical need for objective middle-age screening tools that capture cumulative physiological risk before irreversible functional impairment takes hold.
Because biological aging cannot be directly quantified through a single direct measurement, the investigators collaborated with colleagues from the Max Planck Institute for Biology of Aging in Cologne, Germany, to investigate chemical signatures circulating in human blood. The team analyzed blood specimens gathered from 44,000 volunteers who had been longitudinally monitored across 12 distinct epidemiological studies conducted throughout Europe. Using detailed laboratory assays, the scientists evaluated more than 200 biological substances, capturing broad metabolic profiles that encompassed circulating fat fractions, blood sugar measurements, and established markers of systemic inflammation.
Over the longitudinal follow-up period across the European cohorts, 5,500 participant deaths were documented among the monitored volunteers. By examining the blood profiles of these deceased individuals against surviving cohort members, the investigators identified which specific circulating substances functioned as biological warning indicators for elevated mortality risk. To refine these prognostic markers into a practical tool suitable for routine clinical intervention, the Leiden researchers subsequently established an international collaboration with Brazilian investigator Gabriela Natalle Lopes, an exchange student from the Albert Einstein Israelite Faculty in São Paulo.
The metabolic scoring instrument was subsequently refined across three structured methodological phases. First, the researchers recalibrated the underlying mathematical calculation using population data from the Netherlands, enabling the algorithmic framework to generate a unique and personalized score for each patient. Second, the panel was simplified from hundreds of complex analytical entries to ten established blood markers that practicing physicians routinely evaluate in everyday clinical workflows. Third, the investigators reversed the mathematical scale so that higher numerical values reflect superior biological health, replacing the original framework where elevated scores signified poorer clinical prognosis.
The recalibrated ten-marker indicator demonstrated enhanced precision in predicting the onset of major cardiometabolic disorders, including type 2 diabetes, myocardial infarction, and stroke. Deelen reported that a single-point increment on the updated numerical scale corresponds to an average delay of 14 years before an individual develops their first diagnosed cardiometabolic disease. Furthermore, because the consolidated score reflects general physiological integrity, it exhibits significant positive correlations with multiple established clinical markers of healthy aging, including cognitive test performance, respiratory lung capacity, and handgrip strength measurements reflecting systemic skeletal muscle function.
To evaluate whether the biological score could be actively modified through behavioral interventions, the investigators enrolled volunteer cohorts into structured lifestyle adjustment and progressive resistance training regimens. While aggregate analysis across the entire study cohort did not demonstrate statistically significant shifts in total score, separating participants by their baseline measurements revealed a pronounced divergent pattern. Behavioral modification and exercise produced substantial physiological benefits specifically among higher-risk individuals who began the study with below-average or sub-zero metabolic scores, generating significant reductions in circulating fasting insulin and triglyceride levels alongside measurable improvements in body composition.
Cohort analyses conducted by the research group established that an individual metabolic score is determined 40 percent by inherited genetic factors and 60 percent by environmental exposures and lifestyle behaviors. Among the lifestyle variables assessed, cigarette smoking exerted the single largest negative impact on the metabolic score, whereas consistent physical activity reduced chronic disease risk and improved scoring outcomes. Additionally, early developmental exposures leave persistent biological traces across the life course, with Deelen noting that experiencing severe childhood malnutrition significantly elevates an individual’s metabolic score later in adult life.
The relationship between physical exercise, metabolic status, and functional protection described by the Dutch team aligns with physiological findings presented at FAPESP Week Netherlands by Professor Tiago da Silva Alexandre of the Federal University of São Carlos in Brazil. Alexandre’s investigations demonstrate that musculoskeletal aging and dementia are connected through continuous molecular communication, or crosstalk, operating between four organ systems: skeletal muscle, bone, adipose tissue, and the brain. During muscular contraction and bodily movement, muscle fibers secrete protective signaling peptides known as myokines; however, age-related fat infiltration within muscle fibers disrupts this pathway, impairing contractile performance, altering lipid and carbohydrate metabolism, and increasing risks for metabolic syndrome, functional mobility loss, and dementia.
Alexandre’s research further identifies a damaging biological cascade involving visceral adiposity, vitamin D availability, and neurocognitive decline. Excess abdominal adipose tissue sequesters circulating vitamin D, depriving skeletal muscle of a hormone vital for protein synthesis and muscle mass maintenance. Because vitamin D also participates directly in preserving central nervous system tissue, its systemic depletion simultaneously accelerates muscular weakness and raises the risk of cognitive decline in older adults. To operationalize these biomarker pathways within public healthcare delivery, the Science Center for the Development of Intelligent Methods in the SUS for the Treatment of People with Dementia was established at the Federal University of São Carlos with FAPESP funding, applying artificial intelligence algorithms to electronic health records and diagnostic imaging to differentiate vascular dementia from Alzheimer’s disease.
Subject of Research: Personalized blood metabolic indicators for predicting chronic disease risk and guiding healthy aging
Article Title: New metabolic marker predicts longevity and risk of chronic diseases
Article References: New metabolic marker predicts longevity and risk of chronic diseases. Original publication (Bibliographic details unavailable.)
Image Credits: AI Generated
DOI: Not provided
Keywords: metabolic marker, cardiometabolic disease, healthy aging, Leiden University Medical Center, FAPESP Week Netherlands, Joris Deelen, Tiago da Silva Alexandre, Federal University of São Carlos, myokines, vitamin D deficiency, visceral fat, strength training, fasting insulin, triglycerides, dementia, CCD-MIDEM, Unified Health System, biological aging

